Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer

Name: Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adjuvant Treatment in Resectable Stage III Colorectal Cancer or Non-Small Cell Lung Cancer
License: Public Domain

Ying Yuan, MD

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

crc (colorectal cancer), non small lung cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 683072
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.